Table 3.
Clinical manifestations of patients | RSV | HPIV | ||||
---|---|---|---|---|---|---|
Positive | Negative | P value | Positive | Negative | P value | |
Wheezing | 0.003 | 0.28 | ||||
Yes | 12 (33.3%) | 24 (66.7%) | 0 (0%) | 36 (100%) | ||
No | 6 (9.4%) | 58 (90.6%) | 2 (3.1%) | 62 (96.9%) | ||
Fever | 0.17 | 0.33 | ||||
Yes | 10 (14.5%) | 59 (85.5%) | 2 (2.9%) | 67 (97.1%) | ||
No | 8 (25.5%) | 23 (74.2%) | 0 (0.0%) | 31 (100%) | ||
Vomiting | 0.46 | 0.79 | ||||
Yes | 6 (14.6%) | 35 (85.4%) | 1 (2.4%) | 40 (97.6%) | ||
No | 12 (20.3%) | 47 (97.7%) | 1 (1.7%) | 58 (98.3%) | ||
Diarrhea | 0.12 | 0.23 | ||||
Yes | 1 (5.6%) | 17 (94.4%) | 1 (5.6%) | 17 (94.4%) | ||
No | 17 (20.7%) | 65 (79.3%) | 1 (1.2%) | 81 (98.8%) | ||
Pneumonia | 0.08 | 0.25 | ||||
Yes | 6 (31.6%) | 13 (68.4%) | 1 (5.3%) | 18 (94.7%) | ||
No | 12 (14.8%) | 69 (85.2%) | 1 (1.2%) | 80 (98.8%) | ||
Cough | 0.21 | 0.39 | ||||
Yes | 11 (15.1%) | 62 (84.9%) | 2 (2.7%) | 72 (97.3%) | ||
No | 7 (25.9%) | 20 (74.1%) | 0 (0%) | 26 (100%) | ||
Runny nose | 0.10 | 0.88 | ||||
Yes | 5 (11.1%) | 40 (88.9%) | 1 (2.2%) | 44 (97.8%) | ||
No | 13 (23.6%) | 42 (76.4%) | 1 (1.8%) | 54 (98.2%) | ||
Cyanosis | 0.63 | 0.83 | ||||
Yes | 0 (0%) | 1 (100%) | 0 (0%) | 2 (100%) | ||
No | 18 (18.2%) | 81 (81.8%) | 2 (2%) | 96 (98%) | ||
Tachypnea | 0.005 | 0.69 | ||||
Yes | 4 (57.1%) | 3 (42.9%) | 0 (0%) | 7 (100%) | ||
No | 14 (15.1%) | 79 (84.9%) | 2 (2.2%) | 91 (97.8%) | ||
Shortness of breath | 0.85 | 0.016 | ||||
Yes | 5 (19.2%) | 21 (80.8%) | 2 (7.7%) | 24 (92.3%) | ||
No | 14 (17.6%) | 61 (82.4%) | 0 (0%) | 74 (100%) |
Abbreviations. RSV: respiratory syncytial virus; HPIV-3: human parainfluenza virus 3.